These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis. Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962 [TBL] [Abstract][Full Text] [Related]
6. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G; J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219 [TBL] [Abstract][Full Text] [Related]
7. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Turco MA; Buchbinder M; Popma JJ; Weissman NJ; Mann T; Doucet S; Johnson WL; Greenberg JD; Leadley K; Russell ME Catheter Cardiovasc Interv; 2006 Sep; 68(3):379-88. PubMed ID: 16892434 [TBL] [Abstract][Full Text] [Related]
8. Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. Ashby DT; Dangas G; Aymong EA; Iakovou I; Kuepper F; Mehran R; Stone GW; Leon MB; Moses JW J Am Coll Cardiol; 2003 Mar; 41(5):749-52. PubMed ID: 12628717 [TBL] [Abstract][Full Text] [Related]
9. Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: the Symbiot II trial. Laarman GJ; Kiemeneij F; Mueller R; Guagliumi G; Cobaugh M; Serruys PW; Catheter Cardiovasc Interv; 2005 Mar; 64(3):361-8. PubMed ID: 15736242 [TBL] [Abstract][Full Text] [Related]
10. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662 [TBL] [Abstract][Full Text] [Related]
11. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry. Sanmartin M; Baz JA; Lozano I; de la Torre JM; Hernandez JM; Bordes P; Mainar V; Mauri J; Iñiguez A Catheter Cardiovasc Interv; 2007 Feb; 69(3):372-7. PubMed ID: 17195194 [TBL] [Abstract][Full Text] [Related]
12. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ; Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097 [TBL] [Abstract][Full Text] [Related]
14. Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study. Saia F; Lemos PA; Arampatzis CA; Hoye A; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW Catheter Cardiovasc Interv; 2004 Apr; 61(4):455-60. PubMed ID: 15065137 [TBL] [Abstract][Full Text] [Related]
15. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients. Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238 [TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome after implantation of medium Palmaz (biliary) stents in very large native coronary arteries. Chio FL; Liu MW; Al-Saif SM; Khan MA; Lawson D; Al-Mubarak N Catheter Cardiovasc Interv; 2002 May; 56(1):35-9. PubMed ID: 11979531 [TBL] [Abstract][Full Text] [Related]
17. Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice. Belardi JA; Cura F; Albertal M; Padilla L; Solioz G; Balino PP; Pascua JA; Fava C; Berrocal D; Mendiz O; Grinfeld L Coron Artery Dis; 2005 Aug; 16(5):327-30. PubMed ID: 16000892 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589 [TBL] [Abstract][Full Text] [Related]
19. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C; Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546 [TBL] [Abstract][Full Text] [Related]